Ticker AIKI – Aikido Pharma Inc – sales, description, marketcap – Tickerday.com

AIKI

Aikido Pharma Inc

–

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 20.71M; Volume: 386.00K; AvgVol 3m: 3.63M; Beta: 1.75;

Cost estimate:

P/E: –; EPS: -2.07; EPS growth quarter/prev quarter: 76.90%;

EPS growth this year: -282.90%; EPS growth past 5 years: 57.80%;

EPS ttm: -2.07;

P/S: 2376.14; P/B: 0.61; P/Cashflow: 0.73; P/FCF: ;

Sales: 10.00K; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -69.70%; ROE – return on equity: -72.80%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;

Dividend: –; Dividend Yield (%): –;

Insider Ownership: 5.64%; Insider Transactions:0.00%;

Institutional Ownership: 13.30%; Institutional Transactions: ;

Data update: 07.10.2020.